Cargando…
Tumor immunology Volume 130 /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cambridge, UK :
Academic Press is an imprint of Elsevier,
2016.
|
| Colección: | Advances in immunology ;
v. 130. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn941779216 | ||
| 003 | OCoLC | ||
| 005 | 20231120112055.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 160229s2016 enk o 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d UIU |d OPELS |d N$T |d YDXCP |d CDX |d IDEBK |d EBLCP |d OCLCF |d OCLCQ |d ESU |d MERUC |d D6H |d OCLCQ |d UKMGB |d OCLCQ |d OCLCO |d OCLCQ |d AAA |d SFB |d OCLCO | ||
| 015 | |a GBB627901 |2 bnb | ||
| 016 | 7 | |a 017750312 |2 Uk | |
| 019 | |a 942843655 |a 948792408 |a 1344161913 | ||
| 020 | |a 9780128096550 |q (electronic bk.) | ||
| 020 | |a 0128096551 |q (electronic bk.) | ||
| 020 | |z 9780128051566 | ||
| 020 | |z 0128051566 | ||
| 035 | |a (OCoLC)941779216 |z (OCoLC)942843655 |z (OCoLC)948792408 |z (OCoLC)1344161913 | ||
| 050 | 4 | |a RC268.3 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.99/4 |2 23 |
| 245 | 0 | 0 | |a Tumor immunology |n Volume 130 / |c edited by Robert D. Schreiber. |
| 264 | 1 | |a Cambridge, UK : |b Academic Press is an imprint of Elsevier, |c 2016. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Advances in immunology ; |v v. 130 | |
| 500 | |a Includes index. | ||
| 588 | 0 | |a Online resource; title from PDF title page (ScienceDirect, viewed March 3, 2016). | |
| 504 | |a Includes bibliographical references at the end of each chapters and index. | ||
| 505 | 0 | |a Front Cover; Tumor Immunology; Copyright; Contents; Contributors; Preface; Chapter One: Mouse Models of Tumor Immunotherapy; 1. Introduction; 2. Transplantable Tumor Models; 3. Genetically Engineered Tumor Models; 4. Carcinogen-Induced Tumor Models; 5. Humanized Mouse Tumor Models; 6. Perspectives; 7. Materials and Methods; 7.1. BALB/c MMTV-Her2 Mammary Carcinoma; 7.2. MCA-Induced Fibrosarcoma; Acknowledgments; References; Chapter Two: The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer; 1. Introduction | |
| 505 | 8 | |a 2. Cancer Immunoediting as an Encompassing Model of Immune System-Tumor Interactions2.1. Elimination; 2.2. Equilibrium; 2.3. Escape; 3. Antigenic Targets of Cancer Immunoediting; 4. Setting the Groundwork: Genomic Approaches to Cancer Antigen Identification; 5. Developing Cancer Immunotherapies Based on Genomic Identification of Tumor-Specific Neoantigens; 5.1. Epitope Prediction Algorithms; 5.2. Retrospective Bioinformatic Analyses of Previously Identified Cancer Neoantigens | |
| 505 | 8 | |a 5.3. Experimental Evidence from Preclinical Cancer Models That Neoantigens Form the Basis for Effective Personalized Canc...6. Neoantigens as Therapeutic Targets in HumanCancer; 6.1. Neoantigens in Adoptive Cellular Therapy in Humans; 6.2. Neoantigens as Targets of Tcells Activated by Checkpoint Blockade in Humans; 6.3. The Use of Neoantigen Cancer Vaccines in Humans; 7. Concluding Remarks; Acknowledgments; References; Chapter Three: Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy | |
| 505 | 8 | |a 5. Germline Genetic Differences as an Additional Source of Interpatient Heterogeneity6. Conclusions and Implications; References; Chapter Four: Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Class ...; 1. Introduction; 1.1. Control of Cancer Growth Through Adaptive Immunity; 1.1.1. Immunosurveillance of Cancer; 1.1.2. Tumor Antigens; 1.1.3. Tumor Control by the Tumor Microenvironment (TME); 1.2. Inflammation and Cancer; 1.2.1. Inflammation Promotes Carcinogenesis; 1.2.2. Inflammatory Mediators Promote Cell Survival and Cell Proliferation | |
| 650 | 0 | |a Tumors |x Immunological aspects. | |
| 650 | 6 | |a Tumeurs |x Immunologie. |0 (CaQQLa)201-0049657 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Tumors |x Immunological aspects |2 fast |0 (OCoLC)fst01158775 | |
| 700 | 1 | |a Schreiber, Robert, |d 1946- |e editor. | |
| 776 | 0 | 8 | |i Print version : |z 9780128051566 |
| 830 | 0 | |a Advances in immunology ; |v v. 130. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128051566 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00652776/130 |z Texto completo |